Rabia Khan, Fareeha Arshad, Israr U Hassan, Gowhar A Naikoo, Mona Z Pedram, Mohammed Saeedi Zedegan, Hamed Pourfarzad, Alaa A A Aljabali, Ángel Serrano-Aroca, Yusuf Haggag, Vijay Mishra, Yachana Mishra, Martin Birkett, Murtaza M Tambuwala
Prostate cancer is one of the most common health hazards for men worldwide, specifically in Western countries. Rapid prostate cancer screening by analyzing the prostate-specific antigen present in male serum has brought about a sharp decline in the mortality index of this disease. Immunoassay technology quantifies the target analyte in the sample using the antigen-antibody reaction. Immunoassays are now pivotal in disease diagnostics, drug monitoring, and pharmacokinetics. Recently, immunosensors have gained momentum in delivering better results with high specificity and lower limit of detection (LOD)...
November 2022: Biomedicine & Pharmacotherapy